Abstract: The invention relates to a multipart sprocket (1), in which an inner ring (2) for fixing the multipart sprocket (1) to a wheel hub comprises through-holes (5) which are located on a common hole circle, wherein the inner ring (2) on the periphery thereof comprises radially outwardly directed inner ring lugs (2A) for receiving a gear rim (8), and the gear rim (8) comprises radially inwardly directed gear rim lugs (11) which are spatially associated with the radially outwardly directed inner ring lugs (2A), and means (12, 13, 14) are present, which connect the inner ring (2) and the gear rim (8) axially and radially.

Abstract: The invention relates to a multipart sprocket (1), in which an inner ring (2) for fixing the multipart sprocket (1) to a wheel hub comprises through-holes (5) which are located on a common hole circle, wherein the inner ring (2) on the periphery thereof comprises radially outwardly directed inner ring lugs (2A) for receiving a gear rim (8), and the gear rim (8) comprises radially inwardly directed gear rim lugs (11) which are spatially associated with the radially outwardly directed inner ring lugs (2A), and means (12, 13, 14) are present, which connect the inner ring (2) and the gear rim (8) axially and radially.

Abstract: A clamping tool having a first jaw connected to a pull/push rod and a fixed second jaw connected to a housing which includes a handle disposed opposite the second jaw and arranged along side a grip provided on the housing. Displacement of the handle towards the grip moves the first jaw towards the second jaw and towards a clamping position in a stepwise manner while reverse movement of the rod and jaws is blocked by a detent member. Release of the detent member is provided by a release lever. The release lever can also be utilized, in conjunction with the detent member, to move the rod and first jaw in a release direction. Movement of the rod and first jaw in the clamping direction is caused by engagement of the rod by a carry-along member. The carry-along member, in turn, is engaged by an operating arm which, in turn, is engaged by the handle. The operating arm is slidably connected to the housing thereby enabling the overall length of the operating arm and handle to be varied.

Abstract: The fumaric acid salt of 2-{3-[4-(2-t-butyl-6-trifluoromethyl-4-pyrimidinyl)-1-piperazinyl]propylthio}-4-pyrimidinol is useful for treating disorders which respond to dopamine D3 ligands. It has higher stability at low pH and is therefore particularly suitable for oral administration in pharmaceutical compositions comprising this salt.

Abstract: Triazole compounds of the following formula: where Ar1, A, B and Ar2 have the meanings given in the description, possess a high affinity for the dopamine D3 receptor and can therefore be used for treating diseases which respond to dopamine D3 ligands.

Abstract: The fumaric acid salt of 2-{3-[4-(2-t-butyl-6-trifluoromethyl-4-pyrimidinyl)-1-piperazinyl]propylthio}-4-pyrimidinol is useful for treating disorders which respond to dopamine D3 ligands. It has higher stability at low pH and is therefore particularly suitable for oral administration in pharmaceutical compositions comprising this salt.

Abstract: Aza- and diazacyclohexane and -cyclooctane compounds of the following formula: Ar1—A—B—Ar2  (I) where Ar1, A, B and Ar2 have the meanings stated in the description have a high affinity for the dopamine D3 receptor and can therefore be used to treat disorders which respond to dopamine D3 ligands.

Abstract: The fumaric acid salt of 2-{3-[4-(2-t-butyl-6-trifluoromethyl-4-pyrimidinyl)-1-piperazinyl]propylthio}-4-pyrimidinol is useful for treating disorders which respond to dopamine D3 ligands. It has higher stability at low pH and is therefore particularly suitable for oral administration in pharmaceutical compositions comprising this salt.

Abstract: Aza- and diazacyclohexane and -cyclooctane compounds of the following formula: Ar1—A—B—Ar2  (I) where Ar1, A, B and Ar2 have the meanings stated in the description have a high affinity for the dopamine D3 receptor and can therefore be used to treat disorders which respond to dopamine D3 ligands.